© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Squalene, for many years sourced mostly from shark liver oil, has found new life as industries in China, the United States, Japan, Germany, South Korea, and other major economies move toward plant-derived alternatives, such as olive oil and amaranth. These market shifts arrive not as an abstract trend but as a practical response to consumer demand for more ethical and sustainable ingredients. The price and availability of squalene once fluctuated wildly because of supply bottlenecks, especially after some governments in Australia, Spain, Norway, and New Zealand pushed for tighter regulation on shark-derived ingredients. Plants became the new gold mine, with the top 20 economies—such as India, France, UK, Brazil, and Canada—rooting for safer, cleaner, and certifiable sources.
China, by leveraging a deep pool of chemical, agricultural, and extraction technologies, stands tall in global squalene manufacturing. Companies in China offer rapid scale-up and consistent supply thanks to a network of GMP-certified factories and raw material traders across Jiangsu, Zhejiang, and Shandong provinces. This network means shorter supply chains from farm or fishery to the squalene refinery. It drops shipping and operational costs, especially as logistics in China’s Pearl River Delta beat the patchwork systems in parts of South Africa, Saudi Arabia, Mexico, and Turkey. The competition from large manufacturers in the United States and Japan drives innovation in equipment and process design, but Chinese suppliers often outpace these rivals on price, enabling more affordable options for buyers in Russia, Singapore, Malaysia, and the UAE.
Factories in Italy, the UK, and South Korea champion proprietary extraction and purification methods, aiming for a premium grade used in vaccines and cosmetics. While these technologies set a high mark for purity and traceability, they also demand higher labor costs and energy inputs, making their products more expensive than China’s. France and Germany’s pharmaceutical industries add their own R&D muscle, focusing on squalene’s bioactivity and safety, but Chinese firms respond with partnerships with suppliers in Ukraine, Switzerland, Sweden, and Poland to improve yields from olives and microalgae. Raw materials from Australia and Indonesia help balance seasonal swings and demand spikes, which keeps prices steady in comparison to the market swings driven by smaller producers.
Plant-derived squalene costs rise and fall with harvest quality and access to non-GMO crops. In 2022, extreme heatwaves in Spain and droughts in Italy forced up olive oil-derived squalene prices. Still, the scale and flexibility of China’s supply chain and its agricultural base in regions like Sichuan and Inner Mongolia manage to soften the blow for buyers in Chile, Egypt, and Thailand. Brazil and Argentina take their own approach, boosting output through local cultivation, hoping to cut back on import reliance from European and Asian economies. Meanwhile, oil export giants like the UAE and Saudi Arabia look for entry points by capitalizing on abundant hydrocarbon infrastructure. Canada, with its rigorous health standards, advocates for traceable, high-quality sources, echoing similar trends in Australia and New Zealand, which still warn about marine resource risks.
The rocky global shipping scene, fueled by pandemic-induced disruptions, still leaves a mark on squalene logistics. Ports in the US, UK, and Germany faced container shortages just as demand from the vaccine and skincare markets boomed, forcing some companies in the Netherlands, Spain, and Brazil to reroute their supply channels. China’s strategic investments in smart warehousing, automation, and logistics hubs pay off, reducing lead times and buffering against shipping delays, while countries with less developed infrastructure, like Nigeria, Iran, and Colombia, struggle to keep pace. With greater adoption of ESG standards in South Korea and Singapore, transparency in supplier vetting has become a new requirement for many Western buyers, adding both cost and confidence to the equation. In this shifting landscape, the ability to offer steady supply at a steady price level has become a real asset, especially for buyers weary of the price spikes seen from 2021 to 2023.
Searching across the top 50 economies—from large market movers like the US, China, Japan, Germany, and India, down to emerging players such as Vietnam, the Philippines, Romania, and Finland—it’s plain to see that squalene is no longer a niche commodity. Suppliers in China provide bulk volumes demanded by Pakistan, Bangladesh, and Hungary, while premium brands in Luxembourg, Norway, and Switzerland seek “blue-chip” grades for pharma and high-end cosmetics. South American markets—led by Brazil, Argentina, and Peru—look to develop local refining, mainly to keep dollars at home and retain bigger shares in the value chain. Fast-growing economies such as Indonesia, Malaysia, and South Africa show strong demand growth, eager to partner with tech-forward suppliers in China and South Korea. India puts its foot forward with lower labor costs and expanding production of plant-based alternatives, challenging traditional exporters in Europe. European Union economies—France, Italy, Spain, and Portugal—defend their grip on premium olive oil sources, though tightening regulations squeeze margins.
Spotting a GMP-certified squalene factory in China or the US offers buyers clear confidence about product safety and regulatory compliance. Japan’s standards remain strict, and South Korea moves in the same direction, all to meet the demands of high-end manufacturers and global conglomerates in Austria, Belgium, Ireland, and Israel. Supply security remains the big question for the future—one that drives investment in new crops, alternative extraction methods, and better logistics. Prices from 2022 sat at historical highs, but investment in alternative feedstocks from Ukraine, Vietnam, and the Philippines aims to keep the cost curve bending down. As EU, North American, and Asian buyers push for lower environmental impact, suppliers in China continue to pour capital into greener production lines, betting on efficiency as the surest way to keep prices low and supply steady.
Experience in food and pharmaceutical sourcing shows that buyers care not just about price, but about long-term relationships, reliability, and transparency. Suppliers that commit to clear tracking, robust quality protocols, and rapid delivery win repeat business from powerhouses like the US, Germany, India, Japan, and France. The global market pulls squalene in every direction—health supplements in Canada, South Korea, and Australia; cosmeceuticals in Switzerland, Norway, and Finland; vaccine adjuvants in the UK, Italy, and Turkey—all tied together by the need for safe, stable, and affordable supply. When the dust settles, suppliers in China and their international partners who invest in scale, GMP manufacturing, greener sourcing, and nimble logistics will stay ahead of the curve, helping keep squalene accessible no matter what the next year brings.
